Hepatitis D - 51 Studies Found
Completed |
: Efficacy of Peginterferon Alfa-2b in Previously Untreated Subjects With Chronic Hepatitis B and D Co-infection (Study P04603) :
: 2008-05-27 : Biological: Peginterferon alfa-2b (PegIntron, SCH 54031) Peginterferon alfa-2b 1.5 mcg/kg/wk subcutaneou |
Terminated |
: Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic HBV :
: 2015-10-14 :
|
Active, not recruiting |
: REP 2139-Ca / Pegasys™ Combination Therapy in Hepatitis B / Hepatitis D Co-infection : Chronic HBV Infection (HBeAg Negative) : 2014-09-01 : Drug: REP 2139-Ca + Pegasys (TM) 15 weeks of REP 2139-Ca (500mg QW IV) followed by: 15 weeks of REP 2139 |
Active, not recruiting |
: Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta :
: 2005-06-30 : Drug: pegylated IFN alfa-2b plus ribavirin |
Completed |
: Hepatitis Delta Infections in Hemophiliacs :
: 2000-05-25 : Other: No interventions - observational study |
Active, not recruiting |
: A Study of Pegasys (Peginterferon Alfa 2a) Alone or in Combination With Tenofovir in Patients With Chronic Hepatitis D. : Hepatitis D, Chronic : 2010-03-16 :
|
Active, not recruiting |
: Pegylated Interferon Alone or in Combination With Ezetimibe for Patients With Chronic Hepatitis D : Hepatitis D, Chronic : 2017-03-26 :
|
Completed |
: A Study of Pegylated Interferon (PEG-IFN) Alfa-2a (Pegasys) in Participants With Chronic Hepatitis D (CHD) : Hepatitis D, Chronic : 2016-04-05 : Drug: Pegylated Interferon (PEG-IFN) alfa-2a Participants received pegylated interferon (PEG-IFN) alfa-2 |
Completed |
: A Study of Peginterferon Alfa-2a With or Without Ribavirin in Participants With Chronic Hepatitis D (CHD) : Hepatitis D, Chronic : 2016-04-01 :
|
Terminated |
: An Observational Study on the Prevalence of Chronic Hepatitis D in Romania and the Efficacy of Treatment With Pegasys (Peginterferon Alfa-2a) : Hepatitis D, Chronic : 2013-05-02 |